Nature Communications (Oct 2018)

Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance

  • Fei Chen,
  • Qilai Long,
  • Da Fu,
  • Dexiang Zhu,
  • Yan Ji,
  • Liu Han,
  • Boyi Zhang,
  • Qixia Xu,
  • Bingjie Liu,
  • Yan Li,
  • Shanshan Wu,
  • Chen Yang,
  • Min Qian,
  • Jianmin Xu,
  • Suling Liu,
  • Liu Cao,
  • Y. Eugene Chin,
  • Eric W.-F. Lam,
  • Jean-Philippe Coppé,
  • Yu Sun

DOI
https://doi.org/10.1038/s41467-018-06860-4
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 19

Abstract

Read online

Tumour microenvironment actively contributes to drug resistance in clinical oncology. Here, the authors show that genotoxic stress induces senescence in human stromal cells, which in turn secrete serine protease inhibitor Kazal type 1 (SPINK1) and promote acquired resistance of cancer cells via EGFR-mediated paracrine signaling.